Volume 23, Issue 2, Pages (February 2015)

Slides:



Advertisements
Similar presentations
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Advertisements

Volume 19, Issue 2, Pages (February 2011)
Volume 67, Issue 2, Pages (February 2005)
Volume 19, Issue 1, Pages (January 2011)
Hon-Wai Koon, Dezheng Zhao, Hua Xu, Collin Bowe, Alan Moss, Mary P
Volume 25, Issue 2, Pages (August 2006)
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 143, Issue 5, Pages e1 (November 2012)
Volume 43, Issue 4, Pages (October 2015)
Volume 136, Issue 2, Pages (February 2009)
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Volume 130, Issue 2, Pages (February 2006)
Volume 152, Issue 3, Pages (February 2017)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 145, Issue 2, Pages e10 (August 2013)
Volume 146, Issue 5, Pages e1 (May 2014)
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)  Yehudith Azar, Reut.
Volume 25, Issue 4, Pages (April 2014)
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Volume 145, Issue 2, Pages e10 (August 2013)
Volume 128, Issue 4, Pages (April 2005)
Volume 141, Issue 5, Pages (November 2011)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 132, Issue 3, Pages (March 2007)
Volume 128, Issue 5, Pages (May 2005)
Volume 135, Issue 3, Pages e5 (September 2008)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Volume 23, Issue 5, Pages (May 2015)
Volume 25, Issue 11, Pages (November 2017)
Volume 130, Issue 2, Pages (February 2006)
Volume 22, Issue 3, Pages (March 2014)
Volume 139, Issue 6, Pages (December 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 143, Issue 1, Pages (July 2012)
Volume 145, Issue 2, Pages (August 2013)
Volume 25, Issue 8, Pages (August 2017)
Volume 128, Issue 3, Pages (March 2005)
Volume 29, Issue 6, Pages (December 2008)
Volume 9, Issue 4, Pages (April 2004)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 67, Issue 2, Pages (February 2005)
Volume 146, Issue 7, Pages e4 (June 2014)
Volume 18, Issue 9, Pages (September 2010)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 20, Issue 2, Pages (February 2012)
Volume 18, Issue 4, Pages (April 2010)
Volume 41, Issue 4, Pages (October 2014)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Volume 41, Issue 4, Pages (October 2014)
Volume 19, Issue 2, Pages (February 2011)
Volume 15, Issue 11, Pages (November 2007)
Volume 22, Issue 7, Pages (July 2014)
Volume 11, Issue 6, Pages (June 2005)
Volume 26, Issue 2, Pages (February 2018)
Volume 136, Issue 7, Pages (June 2009)
Volume 20, Issue 6, Pages (June 2012)
Volume 15, Issue 9, Pages (September 2007)
Volume 18, Issue 6, Pages (June 2010)
Volume 19, Issue 1, Pages (January 2011)
Volume 24, Issue 1, Pages (January 2006)
Systemic Administration of Platelets Incorporating Inactivated Sendai Virus Eradicates Melanoma in Mice  Tomoyuki Nishikawa, Li Yu Tung, Yasufumi Kaneda 
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Volume 25, Issue 6, Pages (June 2017)
Engraftment of Bone Marrow–derived Stem Cells to the Lung in a Model of Acute Respiratory Infection by Pseudomonas aeruginosa  Joanna Rejman, Carla Colombo,
Volume 17, Issue 2, Pages (February 2009)
Presentation transcript:

Volume 23, Issue 2, Pages 339-351 (February 2015) Targeted 25-hydroxyvitamin D3 1α-hydroxylase Adoptive Gene Therapy Ameliorates DSS-induced Colitis Without Causing Hypercalcemia in Mice  Bo Li, David J Baylink, Michael H Walter, Kin-Hing William Lau, Xianmei Meng, Jun Wang, Andriy Cherkas, Xiaolei Tang, Xuezhong Qin  Molecular Therapy  Volume 23, Issue 2, Pages 339-351 (February 2015) DOI: 10.1038/mt.2014.201 Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Engraftment of CD11b+/Gr1+ monocytes at the inflamed colon of mice with dextran sulfate sodium (DSS)-induced colitis. (a and b) DSS colitis in 8-week-old C57BL/6 mice was induced as described in Materials and Methods. Gr1+ monocytes were isolated from C57BL/6 mice, labeled with far-red dye and injected, via tail vein, into colitis mice (5 × 106 cells per mouse) at day 7 of the DSS treatment. At day 8 or 10 (1 or 3 days post-cell infusion), mice were perfused with phosphate-buffered saline and the tissue samples were collected for imaging. (a) Ex vivo imaging of far-red dye labeled monocytes in frozen tissue sections at day 1 post-cell infusion. (b) Ex vivo imaging of far-red dye labeled monocytes in frozen tissue sections at day 3 post-cell infusion. Arrows indicate labeled monocytes in organs of injected mice. Images show ×100 original magnifications. Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Mac1 promoter was able to yield high levels of transgene expression in activated macrophages. (a) The lentiviral vector contains a central polypurine tract (cPPT) for efficient nuclear entry, and self-inactivating deletion in the U3 region of the LTRs. The cis-acting partial Gag sequence (Gag) and Rev-response element (RRE) sequences are also indicated. WPRE (woodchuck hepatitis post-transcriptional regulatory element) element is included to enhance marker gene expression. (b) Sca1+ HSCs were isolated from bone marrow cells of C57BL/6 mice, transduced with the lentiviral vector Mac1-GFP-PGK-mCherry, and injected via tail vein into recipient mice. Five weeks post-bone marrow transplantation, peritoneal macrophages and splenocytes were isolated and further treated with 50 ng/ml phorbol 12-myristate 13-acetate for 16 hours. Expression of the marker gene, GFP, was visualized under fluorescent microscopy (×200 magnification). (c) Bone marrow CD11b+Gr1+ monocytes were isolated from the bone marrow transplants and then treated with macrophage colony-stimulating factor for 7 days. Expression of the GFP marker gene was visualized under fluorescent microscopy at day 3 and day 7 (×200 magnification). Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Adoptive transfer of CD11b+/Gr1+ monocytes overexpressing CYP27B1 ameliorated dextran sulfate sodium (DSS)-induced colitis without causing hypercalcemia. (a) Six-week-old C57BL/6 mice were transplanted with Sca1+ HSCs transduced with the Mac1-CYP (Mac1-hCYP27B1-PGK-mCherry) or the Mac1-GFP (Mac1-GFP-PGK-mCherry) lentiviral vector. At the age of 8 weeks, each recipient mouse was treated with DSS to induce colitis. At day 7 of the DSS treatment, mice were injected via tail vein with 4 × 106 Gr1+ monocytes that were isolated from the bone marrow transplants. (b) Body weights were recorded during disease induction and recovery period. (c) Survival rate was recorded daily. (d) At day 13 (6 days post-monocytes infusion), mice were sacrificed and the colon length was measured. (e) Serum concentrations of calcium were measured 6 days post-monocytes infusion. Data from one of the two independent experiments are shown as means ± SEM (n = 5–7). (f) Representative H&E staining of distal colon cross-sections. All images are shown at 20× magnification. (g) Histological score was measured in cross-sections of the distal colon. Data are presented as means ± SEM (n = 10–12) pooled from two independent experiments. (h) Mucosal regeneration index was determined at cross-sections of the distal colon (Material and Methods). Data of the representative of the two independent experiments are presented as means ± SEM (n = 4–5). *P < 0.05, **P < 0.01, or ***P < 0.001 versus DSS-treated mice. Mo, monocytes. Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Adoptive transfer of CD11b+/Gr1+ M2 macrophages overexpressing CYP27B1 improved IBD pathology. (a and b) M2 macrophages were transduced with the indicated lentiviral vectors and were incubated with 2.5 μmol/l 25(OH)D3 for 20 hours (Materials and Methods). (a) Human CYP27B1 mRNA level was measured by real-time qRT-PCR. Data are shown as means ± SEM (n = 4). ***P < 0.001. (b) 1,25(OH)2D3 concentration in the conditioned media pooled from triplicate samples was measured by radioimmunoassay. (c) Colitis induction in 8-week-old C57BL/6 mice and M2 macrophages adoptive transfer were performed described in Material and Methods. On day 13 (6 days post-macrophages infusion), mice were sacrificed, and the colon samples were collected. Representative H&E staining images of the frozen distal colon sections were shown. All images are shown at 20× magnification. (d) Histological score of colon sections was determined as described in Materials and Methods. Data are presented as means ± SEM (n = 5). (e) Mucosal regeneration index was determined as described in Material and Methods. Data are presented as means ± SEM (n = 4–5). **P < 0.01, or ***P < 0.001 versus dextran sulfate sodium-treated mice. M2Ø, M2 macrophages. Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Adoptive transfer of CD11b+/Gr1+ monocytes overexpressing CYP27B1 reduced the expression of inflammatory cytokines in the colon of mice with dextran sulfate sodium (DSS)-induced colitis. The experimental design was described in Figure 3. (a) Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis of the mRNA levels of proinflammatory cytokines produced mainly by macrophages/dendritic cells. (b) Real-time qRT-PCR analysis of the mRNA level of IFN-γ, a pathogenic Th1-specific cytokine in the colon. (c) Real-time qRT-PCR analysis of the mRNA level of IL-17a, a pathogenic Th17-specific cytokine in the colon. Data of a representative experiment of two independent experiments are presented as means ± SEM (n = 4–6). *P < 0.05, **P < 0.01, or ***P < 0.001 versus DSS-treated mice. Mo, monocytes. Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 Adoptive transfer of CD11b+/Gr1+ monocytes overexpressing CYP27B1 significantly increased expression of the protective Th2 cytokines. The experimental design was described in Figure 3. Colon and lymph node samples were collected 6 days post-monocytes infusion. (a) mRNA levels of Th2 cytokines in colon were measured by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). (b) mRNA levels of Th2 cytokines in lymph nodes were measured by real-time qRT-PCR. Data are presented as means ± SEM (n = 4–6). *P < 0.05, **P < 0.01 versus dextran sulfate sodium-treated mice. Mo, monocytes. Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 7 Evidence that adoptive transfer of CD11b+/Gr1+ monocytes overexpressing CYP27B1 ameliorated dextran sulfate sodium (DSS)-induced colitis in part through restoring epithelial barrier function. (a and b) The experimental design was described in Figure 3. Colon tissues were collected 6 days post-monocytes infusion. (a,b) The mRNA level of two tight junction genes, claudin-1 and ZO-1, in colon was measured by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Data are presented as means ± SEM (n = 4–6). (c) Monolayers of Caco-2 cells were pretreated with or without 10 nmol/l 1,25(OH)2D3 for 48 hours. 5% DSS was then added to the media for 10 hours before the analysis of gene expression. The mRNA level of ZO-1 and claudin-1 in cultured epithelial cells was determined by real-time qRT-PCR. Data are presented as means ± SEM (n = 4). (d) The effects of 1,25(OH)2D3 on paracellular permeability of epithelial cell monolayers. Epithelial monolayers were obtained by culturing Caco-2 cells on filters in transwells and were treated as described in panel c. The permeability to fluorescein isothiocyanate-conjugated dextran is presented as % of the value in cells treated with DSS only. Data are presented as means ± SEM (n = 3). *P < 0.05, **P < 0.01, or ***P < 0.001 versus DSS-treated group. Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 8 A proposed model of the mechanism by which adoptive CYP27B1 gene therapy acts to ameliorate dextran sulfate sodium-induced colitis. Infused exogenous Gr1+ monocytes or M2 macrophages overexpressing CYP27B1 guided by the Mac1 promoter are recruited to the inflamed colon, where they are activated to express exogenous CYP27B1 to synthesize 1,25(OH)2D3 locally. 1,25(OH)2D3 produced by the activated exogenous macrophages then acts on T cells to cause a switch from the pathogenic Th1-Th17 response to the protective Th2 response. 1,25(OH)2D3 also acts on infiltrating macrophages leading to reduced expression of proinflammatory cytokines. As a result of the reduced inflammation, mucosal regeneration is expedited. In addition, 1,25(OH)2D3 also promotes mucosal regeneration via increasing epithelial tight junction protein synthesis and restoring epithelial barrier function. Molecular Therapy 2015 23, 339-351DOI: (10.1038/mt.2014.201) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions